Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
THE HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA

2. Address

Address1
30 North Third Street
 Address2
​Suite 600
City
Harrisburg
 State
PA
 Zip Code
17101
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mr.
​John Myers
​2028639287
​jmyers@haponline.org
5. Senate ID#
​18672-12
7. Client Name Self Check if client is a state or local government or instrumentality
​THE HOSPITAL & HEALTHSYSTEM ASSOCIATION OF PENNSYLVANIA
6. House ID#
​322910000
TYPE OF REPORT 8. Year
​2022
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​80,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: John Myers
 Date
10/20/2022 2:33:48 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

FY2023 Appropriations bills
NIH funding
Nursing and allied health workforce funding


17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Laura
Kent
​
​
John
Myers
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

Sequestration relief (Protecting Medicare and American Farmers from Sequester Cuts Act - S. 610)
Rural hospital policies [Rural Health Clinic payment - Rural and Underserved Small Hospital Protection Act/RUSH Act (H.R. 1885), Rural HELP Act - HR 1749; Rural Hospital Closure Relief Act (H.R. 1639/S.644)]
Graduate Medical Education (GME) funding (Resident Physician Shortage Reduction Act of 2021 - S. 834/H.R. 2256; Opioid Workforce Act, S. 1438)/ Substance Use Disorder Workforce Act, H.R. 3441)
H.R. 1749 (study on potential disparities in incurred costs for rural and urban hospitals and authorizing appropriate payment adjustments)
S. 439, Coronavirus Medicaid Response Act (addressing FMAP)
Telehealth flexibilities and payment (TREAT Act - S. 168/H.R. 708; Telehealth Modernization Act -S. 368/H.R. 1332; TREATS Act - S. 340; CONNECT for Health Act S. 1512/H.R. 2903; Ensuring Parity in MA and PACE for Audio-Only Telehealth Act S. 150/H.R. 2166; Consolidated Appropriations Act of 2022, HR 2471)
Resetting the Impact (TRIA) Act of 2021 (H.R. 2455)
Prior Authorization reform - Improving Seniors Timely Access to Care Act of 2021 (H.R. 3173/S.3018)
S.586 / H.R. 3259 - Non-Opioids Prevent Addiction In the Nation (NOPAIN) Act
Annual Prospective Payment System Rules
Accelerated and Advance Payment Program repayment flexibility (H.R. 1349, The COVID-19 Hospital and Health Provider Loan Conversion Act of 2021; H.R. 2407, Better Way for Providers to Repay Act of 2021)
S. 408, Supporting Best Practices for Healthy Moms Act (to reduce maternal mortality)
Nursing and allied health education (NAHE) program funding
Technical Reset to Advance the Instruction of Nurses (TRAIN) Act (S. 1568 / HR 4407) - Nursing and allied health education payments
Organ acquisition payment policies
Clinical lab fee schedule
False Claims Act amendments
CMS Omnibus COVID-19 Health Care Staff Vaccination Interim Final Rule
Hospital Inpatient Services Modernization Act (H.R. 7053 /S. 3792) - to extend the hospital at home waiver program
Medicare Mental Health Inpatient Equity Act (S. 3061/H.R. 5674)
HR 4040: Advancing Telehealth Beyond COVID-19 Act
HELP Act
Inpatient Psychiatric Facility Improvement Act
MIND Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Laura
Kent
​
​
John
Myers
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Public Health and Social Services Emergency Fund
Transparency (surprise medical bills; public posting of hospital charges)
340B Drug Pricing Program, including S. 773/H.R. 3203
Resident Physician Shortage Act (S. 834/H.R. 2256)
OSHA rule on COVID-19 Healthcare Workplace Safety
No Surprises Act regulations
Rural health care innovation (PA Rural Health Model and Community Health Access and Rural Transformation Model (CHART)
Public Health Emergency designation
COVID Data Reporting
H.R.7961 - the SAVE Act
Restoring Hope for Mental Health and Well-being Act
Infrastructure Investment and Jobs Act
Dr. Lorna Breen Health Care Provider Protection Act (HR 1667)
Provider Relief Fund Improvement Act (H.R. 5963 / S. 3611)
Public Service Loan Forgiveness program/physician federal loan forgiveness
Healthcare Workforce Resilience Act of 2021
Black Maternal Health Momnibus Act of 2021 (S. 346/H.R. 959)
Conrad State 30 & Physician Access Act
Regulatory relief in light of coronavirus
Vaccine mandate policy
Healthcare Cybersecurity Act (S.3904) - collaboration between the CISA and HHS
H. Res. 909 condemning violence against health care workers
PREVENT Pandemics Act (S. 3799)
Bipartisan Safer Communities Act (S. 2938)
Health Care Capacity for Pediatric Mental Health Act
Kids Mental Health Improvement Act
Continuing Systems of Care for Children Act,
Strengthen Kids Mental Health Now Act
Cost of Mental Illness Act
Community Health Center Mental Health Screening Act
Greater Mental Health Access Act
National Defense Authorization Act
Travel Nursing Agency Transparency Study Act

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Laura
Kent
​
​
John
Myers
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code LBR

16. Specific lobbying issues

OSHA Standards (H.R. 1195)
OSHA Emergency Temporary Standard rule on COVID-19 Healthcare Workplace Safety
OSHA Vaccination and Testing Emergency Temporary Standard

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Laura
Kent
​
​
John
Myers
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)